Actionable news
0
All posts from Actionable news
Actionable news in AMGN: Amgen Inc.,

Amgen submits BLA in U.S. for osteoporosis candidate romosozumab

Amgen (NASDAQ:AMGN) files a Biologics License Application (BLA) with the FDA seeking approval of romosozumab for the treatment of osteoporosis in postmenopausal women at increased risk of...


More